Daniel J. Lippis, the Corporate Vice President for JAPAC at Edwards Lifesciences Corp (NYSE:EW), has disclosed recent stock ...

Wolfe Research adjusted its perspective on Edwards Lifesciences (NYSE:EW) shares, downgrading its rating from Peerperform to ...

Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter ...

Edwards Lifesciences (EW) stock faces a downgrade at Wolfe due to concerns over its TAVR market prospects. Read more here.

Capital Investment Advisors LLC lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.4% during the fourth quarter, according to its most recent disclosure with the ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences (EW – Research Report) today. The company’s shares closed yesterday ...

On Monday, January 13, the U.S. Supreme Court issued an order list denying petitions for writ of certiorari in three cases ...

Harbor Capital Advisors Inc. boosted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.5% during the 4th quarter, according to its most recent disclosure with the ...

The US Supreme Court rejected a case asking the justices to interpret a patent-infringement safe-harbor provision in a ...